|
Volumn 148, Issue 9, 1988, Pages 2058-2064
|
Managment of cancer during pregancy
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMINOPTERIN;
AMSACRINE;
ANTINEOPLASTIC AGENT;
BLEOMYCIN;
BUSULFAN;
CHLORAMBUCIL;
CHLORMETHINE;
CISPLATIN;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DAUNORUBICIN;
DOXORUBICIN;
FLUOROURACIL;
MERCAPTOPURINE;
METHOTREXATE;
PROCARBAZINE;
TETRAMETHYLAMMONIUM HYDROXIDE;
UNCLASSIFIED DRUG;
VINBLASTINE;
VINCRISTINE;
CANCER;
CANCER THERAPY;
CONGENITAL MALFORMATION;
DRUG METABOLISM;
FETUS DEVELOPMENT;
FIRST TRIMESTER PREGNANCY;
HUMAN;
PREGNANCY;
PRIORITY JOURNAL;
REVIEW;
SIDE EFFECT;
TERATOGENESIS;
FEMALE;
FETUS DISEASE;
METABOLISM;
NEWBORN;
PREGNANCY COMPLICATION;
PREMATURITY;
PRENATAL EXPOSURE;
RADIATION DOSE;
RADIATION INJURY;
RISK FACTOR;
THERAPEUTIC ABORTION;
ABNORMALITIES, DRUG-INDUCED;
ABORTION, THERAPEUTIC;
ANTINEOPLASTIC AGENTS;
FEMALE;
FETAL DISEASES;
HUMAN;
INFANT, NEWBORN;
INFANT, PREMATURE;
PREGNANCY;
PREGNANCY COMPLICATIONS, NEOPLASTIC;
PREGNANCY TRIMESTER, FIRST;
PRENATAL EXPOSURE DELAYED EFFECTS;
RADIATION DOSAGE;
RADIATION INJURIES;
RISK FACTORS;
|
EID: 0023821211
PISSN: 00039926
EISSN: None
Source Type: Journal
DOI: 10.1001/archinte.148.9.2058 Document Type: Article |
Times cited : (186)
|
References (0)
|